|Articles|September 28, 2022
Indiana University Melvin and Bren Simon Comprehensive Cancer Center Joins Caris Precision Oncology Alliance
Advertisement
Caris Life Sciences announced that Indiana University Melvin and Bren Simon Comprehensive Cancer Center has joined the Caris Precision Oncology Alliance™ (POA). The POA is a growing network of cancer centers that collaborate to advance oncology and biomarker research.
Established in 1992, the IU Simon Comprehensive Cancer Center is Indiana's sole National Cancer Institute (NCI)-designated comprehensive cancer center. It conducts all phases of cancer research, from laboratory studies to clinical trials to population-based studies.
Read more about the POA
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Tufts CSDD Analysis Finds AI Clinical Monitoring Agent Can Generate Up to $21 Million in Net Financial Value Per Drug Development Program
2
Beyond Compliance: ProofPilot's Joseph Kim and Lauren Briggs on Making Clinical Trial Training Actually Work
3
ACT Brief: Efficacy Ceiling Breakthrough in Autoimmune Disease, Early-Career Retention and Burnout Prevention, and PRV Program Catalyzing Rare Disease Investment
4
The Career They Didn't Train For: Rethinking Early-Career Burnout in Clinical Research
5